Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,853 | 122 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,005 | 30 | $0 (2024) |
| Abbott Laboratories | $729.35 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $261.84 | 6 | $0 (2024) |
| Novo Nordisk Inc | $256.28 | 16 | $0 (2024) |
| Genentech USA, Inc. | $201.71 | 4 | $0 (2022) |
| AbbVie Inc. | $165.67 | 3 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140.55 | 3 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $134.77 | 2 | $0 (2022) |
| Medtronic USA, Inc. | $117.22 | 2 | $0 (2019) |
| Lilly USA, LLC | $107.35 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $632.13 | 16 | Abbott Laboratories ($394.13) |
| 2023 | $509.40 | 15 | Abbott Laboratories ($335.22) |
| 2022 | $355.12 | 14 | Amgen Inc. ($134.07) |
| 2021 | $485.29 | 10 | Amgen Inc. ($173.84) |
| 2020 | $74.88 | 4 | Amgen Inc. ($45.49) |
| 2019 | $711.94 | 18 | Amgen Inc. ($385.87) |
| 2018 | $393.81 | 18 | Amgen Inc. ($164.98) |
| 2017 | $690.85 | 27 | Merck Sharp & Dohme Corporation ($227.54) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 2 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2023 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/06/2023 | LINUS HEALTH, INC. | CORE COGNITIVE EVALUATION (Device) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: DEVICE | ||||||
| 08/29/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Endocrinology | ||||||
| 08/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Diabetes Care | ||||||
| 04/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Obesity | ||||||
| 11/08/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.81 | General |
| 09/21/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: VACCINES | ||||||
| 08/18/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 08/04/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: PENNSAID | ||||||
| 06/29/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.26 | General |
| 06/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 06/08/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $118.39 | General |
| Category: Inflammation | ||||||
| 06/08/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Inflammation | ||||||
| 05/18/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Obesity | ||||||
| 03/14/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Obesity | ||||||
| 02/07/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Virology & Specialty Care | ||||||
| 01/13/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Virology & Specialty Care | ||||||
| 11/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $120.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $115.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 696 | 1,517 | $122,875 | $72,977 |
| 2022 | 16 | 858 | 1,843 | $179,054 | $89,239 |
| 2021 | 20 | 1,058 | 3,255 | $289,106 | $141,040 |
| 2020 | 10 | 681 | 1,466 | $102,460 | $67,041 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 564 | $69,367 | $45,792 | 66.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 217 | $18,241 | $11,581 | 63.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 48 | 128 | $19,200 | $6,164 | 32.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $5,000 | $2,980 | 59.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 145 | 356 | $3,560 | $2,908 | 81.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 65 | 65 | $1,625 | $1,568 | 96.5% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 65 | 65 | $4,225 | $1,309 | 31.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 46 | 48 | $1,116 | $562.52 | 50.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 44 | 54 | $540.00 | $112.20 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 162 | 476 | $58,195 | $38,218 | 65.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 252 | $20,818 | $14,952 | 71.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 51 | 221 | $44,200 | $11,829 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 41 | $6,839 | $4,392 | 64.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 36 | 104 | $15,600 | $4,287 | 27.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 45 | 86 | $12,785 | $4,213 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $4,000 | $2,469 | 61.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 11 | 43 | $2,627 | $1,987 | 75.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 11 | 33 | $2,516 | $1,740 | 69.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 63 | 63 | $1,575 | $1,519 | 96.4% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 64 | 64 | $4,160 | $1,244 | 29.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 140 | 321 | $3,210 | $933.24 | 29.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 56 | $1,272 | $700.84 | 55.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $738.30 | $598.47 | 81.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 28 | 33 | $330.00 | $113.99 | 34.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 19 | $190.00 | $41.80 | 22.0% |
About Dr. Jorge Gardyn, M.D
Dr. Jorge Gardyn, M.D is a Specialist healthcare provider based in Amityville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629060983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jorge Gardyn, M.D has received a total of $3,853 in payments from pharmaceutical and medical device companies, with $632.13 received in 2024. These payments were reported across 122 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,853).
As a Medicare-enrolled provider, Gardyn has provided services to 3,293 Medicare beneficiaries, totaling 8,081 services with total Medicare billing of $370,296. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Amityville, NY
- Active Since 08/22/2005
- Last Updated 04/28/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629060983
Products in Payments
- FREESTYLE LIBRE 3 (Device) $587.50
- Repatha (Biological) $343.10
- Aimovig (Biological) $339.84
- Otezla (Drug) $274.88
- Xofluza (Drug) $201.71
- BELSOMRA (Drug) $197.51
- UBRELVY (Drug) $165.67
- FREESTYLE LIBRE 2 (Device) $141.85
- XARELTO (Drug) $134.77
- JARDIANCE (Drug) $119.37
- Victoza (Drug) $102.82
- RESTORE (Device) $97.38
- iPro2 (Device) $70.00
- Korlym (Drug) $67.72
- MOUNJARO (Drug) $59.42
- PREVNAR - 13 (Biological) $58.00
- Wegovy (Drug) $54.44
- Prolia (Biological) $46.71
- Vascepa (Drug) $43.85
- Dexcom G6 Transmitter (Medical Supply) $42.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Amityville
Dr. Bimalkumar Brahmbhatt, M.d, M.D
Specialist — Payments: $74,424
Dr. Jeffrey Nussbaum, M.d, M.D
Specialist — Payments: $44,748
Dr. Ralph Caselnova, M.d, M.D
Specialist — Payments: $20,536
Dr. James Colasacco, M.d, M.D
Specialist — Payments: $8,694
Dr. Jasjit Singh, D.o, D.O
Specialist — Payments: $2,077
Dr. Zoila Flashner, Md, MD
Specialist — Payments: $1,417